85 related articles for article (PubMed ID: 15504338)
1. Expression and characterization of the first kunitz domain of human tissue factor pathway inhibitor-2.
Kong D; Ma D; Bai H; Guo H; Cai X; Mo W; Tang Q; Song H
Biochem Biophys Res Commun; 2004 Nov; 324(4):1179-85. PubMed ID: 15504338
[TBL] [Abstract][Full Text] [Related]
2. [Cloning, expression and biological characterization of hTFPI-2 gene].
Kong DS; Guo HS; Cai X; Liang W; Peng ZC; Song HY; Ma D
Zhonghua Xue Ye Xue Za Zhi; 2006 Sep; 27(9):606-10. PubMed ID: 17278427
[TBL] [Abstract][Full Text] [Related]
3. Spectroscopic analysis on the effect of temperature on Kunitz domain 1 of human tissue factor pathway inhibitor-2.
Zhang C; Kong D; Liu X; Yan X; Dai L; Ma D
Acta Biochim Biophys Sin (Shanghai); 2007 Jun; 39(6):406-12. PubMed ID: 17558445
[TBL] [Abstract][Full Text] [Related]
4. Expression and characterization of Kunitz domain 3 and C-terminal of human tissue factor pathway inhibitor-2.
Zhu L; Wang J; Mu J; Wang H; Zhang C; Wang J; Liu X; Yan X; Dai L; Ma D
Acta Biochim Biophys Sin (Shanghai); 2009 Nov; 41(11):948-54. PubMed ID: 19902129
[TBL] [Abstract][Full Text] [Related]
5. Structure-function analysis of the reactive site in the first Kunitz-type domain of human tissue factor pathway inhibitor-2.
Chand HS; Schmidt AE; Bajaj SP; Kisiel W
J Biol Chem; 2004 Apr; 279(17):17500-7. PubMed ID: 14970225
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of Kunitz domain 1 (KD1) of tissue factor pathway inhibitor-2 in complex with trypsin. Implications for KD1 specificity of inhibition.
Schmidt AE; Chand HS; Cascio D; Kisiel W; Bajaj SP
J Biol Chem; 2005 Jul; 280(30):27832-8. PubMed ID: 15932872
[TBL] [Abstract][Full Text] [Related]
7. Human tissue factor pathway inhibitor-2 induces caspase-mediated apoptosis in a human fibrosarcoma cell line.
Kempaiah P; Kisiel W
Apoptosis; 2008 May; 13(5):702-15. PubMed ID: 18401718
[TBL] [Abstract][Full Text] [Related]
8. Structural and functional characterization of tissue factor pathway inhibitor following degradation by matrix metalloproteinase-8.
Cunningham AC; Hasty KA; Enghild JJ; Mast AE
Biochem J; 2002 Oct; 367(Pt 2):451-8. PubMed ID: 12117418
[TBL] [Abstract][Full Text] [Related]
9. Engineering kunitz domain 1 (KD1) of human tissue factor pathway inhibitor-2 to selectively inhibit fibrinolysis: properties of KD1-L17R variant.
Bajaj MS; Ogueli GI; Kumar Y; Vadivel K; Lawson G; Shanker S; Schmidt AE; Bajaj SP
J Biol Chem; 2011 Feb; 286(6):4329-40. PubMed ID: 21115497
[TBL] [Abstract][Full Text] [Related]
10. Tissue factor pathway inhibitor-2 is upregulated by vascular endothelial growth factor and suppresses growth factor-induced proliferation of endothelial cells.
Xu Z; Maiti D; Kisiel W; Duh EJ
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2819-25. PubMed ID: 17023682
[TBL] [Abstract][Full Text] [Related]
11. Atypical Kunitz-type serine proteinase inhibitors produced by the ruminant placenta.
MacLean JA; Roberts RM; Green JA
Biol Reprod; 2004 Aug; 71(2):455-63. PubMed ID: 15070828
[TBL] [Abstract][Full Text] [Related]
12. The role of tissue factor pathway inhibitor-2 in cancer biology.
Sierko E; Wojtukiewicz MZ; Kisiel W
Semin Thromb Hemost; 2007 Oct; 33(7):653-9. PubMed ID: 18000791
[TBL] [Abstract][Full Text] [Related]
13. rBmTI-6, a Kunitz-BPTI domain protease inhibitor from the tick Boophilus microplus, its cloning, expression and biochemical characterization.
Sasaki SD; Tanaka AS
Vet Parasitol; 2008 Aug; 155(1-2):133-41. PubMed ID: 18502587
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of DA-125, a new anthracyclin analog antitumor agent, on the invasion of human fibrosarcoma cells by down-regulating the matrix metalloproteinases.
Park HJ; Chung HJ; Min HY; Park EJ; Hong JY; Kim WB; Kim SH; Lee SK
Biochem Pharmacol; 2005 Dec; 71(1-2):21-31. PubMed ID: 16271263
[TBL] [Abstract][Full Text] [Related]
15. Expression, purification, and inhibitory properties of human proteinase inhibitor.
Dahlen JR; Foster DC; Kisiel W
Biochemistry; 1997 Dec; 36(48):14874-82. PubMed ID: 9402754
[TBL] [Abstract][Full Text] [Related]
16. High-level production of active human TFPI-2 Kunitz domain in plant.
Williams L; Deana A; Romero A; Molina A; Lunello P
Protein Expr Purif; 2014 Apr; 96():14-9. PubMed ID: 24486814
[TBL] [Abstract][Full Text] [Related]
17. Role of metalloproteinases MMP-9 and MT1-MMP in CXCL12-promoted myeloma cell invasion across basement membranes.
Parmo-Cabañas M; Molina-Ortiz I; Matías-Román S; García-Bernal D; Carvajal-Vergara X; Valle I; Pandiella A; Arroyo AG; Teixidó J
J Pathol; 2006 Jan; 208(1):108-18. PubMed ID: 16278822
[TBL] [Abstract][Full Text] [Related]
18. [Expression of a shrimp Kunitz-type protease inhibitor in Pichia pastoris and activity analysis].
Chen D; He N; Zhang M
Sheng Wu Gong Cheng Xue Bao; 2008 Mar; 24(3):500-3. PubMed ID: 18589830
[TBL] [Abstract][Full Text] [Related]
19. The interaction of the second Kunitz-type domain (KD2) of TFPI-2 with a novel interaction partner, prosaposin, mediates the inhibition of the invasion and migration of human fibrosarcoma cells.
Xu C; Deng F; Mao Z; Zhang J; Wang H; Wang J; Mu J; Deng S; Ma D
Biochem J; 2012 Jan; 441(2):665-74. PubMed ID: 21943334
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning, expression, and characterization of bovine tissue factor pathway inhibitor-2.
Du X; Deng FM; Chand HS; Kisiel W
Arch Biochem Biophys; 2003 Sep; 417(1):96-104. PubMed ID: 12921785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
